c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming

Richard Marcotte1, Lixin Zhou, Harold Kim

  • 1Goodman Cancer Center, Department of Biochemistry, McGill University, Montreal, Quebec, Canada.

Insights

The epidermal growth factor receptor (EGFR) Y877 motif binds c-Src tyrosine kinase, driving cancer cell transformation. This interaction is crucial for understanding EGFR inhibitor resistance and implicates c-Src in mutant EGFR-driven cancers.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • c-Src tyrosine kinase specifically interacts with ErbB2, a member of the epidermal growth factor receptor (EGFR) family.
  • Previous research identified the kinase region of ErbB2 as necessary for c-Src binding using a chimeric receptor approach.

Purpose of the Study:

  • To pinpoint the specific amino acid motif within EGFR responsible for c-Src binding.
  • To investigate the functional consequences of c-Src binding to EGFR, including cellular transformation.
  • To explore the role of c-Src in EGFR inhibitor resistance, particularly in lung cancer.

Main Methods:

  • Utilized chimeric EGFR/ErbB2 receptors to map the c-Src interaction site.
  • Introduced specific mutations, including the Y877 motif (EGFR(YHAD)), into EGFR constructs.
  • Assessed in vitro and in vivo transformation assays following ligand stimulation.
  • Investigated the role of Stat3 activation and Src inhibitors in EGFR-mediated transformation.
  • Examined EGFR mutants found in lung cancer for their capacity to bind c-Src and their sensitivity to kinase inhibitors.

Main Results:

  • The conserved amino acid motif surrounding tyrosine 877 (EGFR(YHAD)) is sufficient for c-Src binding, independent of Src domains or kinase activity.
  • Chimeric EGFRs with the Y877 motif induced transformation in vitro and in vivo, partially dependent on Stat3 activation.
  • EGFR mutants conferring sensitivity to gefitinib and erlotinib gained the ability to bind c-Src.
  • Src inhibitors blocked transformation by these EGFR mutants, irrespective of their sensitivity to EGFR inhibitors.

Conclusions:

  • The EGFR Y877 motif is a key determinant for c-Src interaction and subsequent cellular transformation.
  • c-Src plays a critical role in mediating transformation induced by EGFR mutants, including those resistant to EGFR inhibitors.
  • Targeting c-Src may offer a therapeutic strategy for cancers driven by EGFR mutants, especially in cases of acquired resistance to EGFR-targeted therapies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...